This GLP-1 release stimulates the brain to suppress appetite, enhances glucose disposal, and improves insulin sensitivity, contributing to metabolic benefits like reduced food intake, obesity, and better glucose tolerance
As of July 1, 2025, CVS Caremark selected Wegovy as its preferred weight loss medication, removing Zepbound from most formularies
As we age, glutathione production decreases, accelerating the ageing process
Since semaglutide helps lower weight and changes how the body handles insulin and other hormones, researchers are asking whether this medicine might indirectly help women with fibroids
For GLP-1s, the benefit of weight loss is often contingent upon continued use of the medication